TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18439175

Group type: EXPERIMENTAL
Intervention: Remote magnetic navigation system (MNS) with an 8‐mm‐tip magnetic catheter for RF ablation (70 degrees C, maximum power 70 W, 90 seconds)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Remote magnetic navigation system (MNS) with an 8‐mm‐tip magnetic catheter for RF ablation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Group 1 (first 14 patients)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Group 2 (remaining patients)
Number of subjects: 26
Study: 17111709

Group type: EXPERIMENTAL
Intervention: Chaste tree fruit (Vitex agnus)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ginger (Zingiber officinale)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cimicifuga racemosa
Number of subjects: 19
Study: 14522623

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 0.05% cream
Number of subjects: 199

Group type: COMPARATOR
Intervention: Hydrocortisone (HC) 1% cream
Number of subjects: 199

Group type: COMPARATOR
Intervention: Hydrocortisone butyrate (HCB) 0.1% cream
Number of subjects: 199
Study: 10972598

Group type: EXPERIMENTAL
Intervention: Milrinone (loading dose of 20 microg/kg followed by infusion of 0.2 microg/kg/min) in low pre-CPB CI group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Milrinone (loading dose of 20 microg/kg followed by infusion of 0.2 microg/kg/min) in high pre-CPB CI group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo in low pre-CPB CI group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo in high pre-CPB CI group
Number of subjects: 48
Study: 8831437

Group type: EXPERIMENTAL
Intervention: Standardized interpersonal psychotherapy
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with nortriptyline
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 157
Study: 1482134

Group type: EXPERIMENTAL
Intervention: Intravenous administration of TIBO (100 mg for 29 days)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Oral administration of TIBO (100 mg, 200 mg, and 100 mg with probenecid daily for 14 days)
Number of subjects: 5
Study: 6531024

Group type: EXPERIMENTAL
Intervention: 8‐MOP plus TMP (combination dose)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Low-dose 8‐MOP (0.3 mg/kg)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: 8‐MOP or combination group of 8‐MOP plus TMP
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: High-dose TMP and psoralen
Number of subjects: 366

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 366
Study: 31909382

Group type: EXPERIMENTAL
Intervention: TAP Block with USG guidance using 0.25% bupivacaine 60 ml (30 ml at each side)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.9% NaCl 60 ml (30 ml at each side) with USG guidance (Control Group)
Number of subjects: 30
Study: 29505512

Group type: EXPERIMENTAL
Intervention: Participants with a past history of hyperglycaemia
Number of subjects: 772

Group type: COMPARATOR
Intervention: Lifestyle habits and risk factors
Number of subjects: 772
Study: 27139477

Group type: EXPERIMENTAL
Intervention: Ceftolozane-tazobactam plus metronidazole
Number of subjects: 55

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 55
Study: 25194966

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 48
Study: 23231750

Group type: EXPERIMENTAL
Intervention: Induction of labour between 39⁰/⁷ and 39⁶/⁷ weeks gestation
Number of subjects: 630

Group type: COMPARATOR
Intervention: Expectant management (awaiting spontaneous onset of labour)
Number of subjects: 630
Study: 20227354

Group type: COMPARATOR
Intervention: Test cigarettes (EHCSS or activated carbon filter)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stopping smoking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cigarettes
Number of subjects: 0
Study: 18679600

Group type: EXPERIMENTAL
Intervention: Weicao Capsule (WCC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tongfengding Capsule (Control)
Number of subjects: 200
Study: 16003661

Group type: EXPERIMENTAL
Intervention: Physical therapy (PT) using treatment-based classification guidelines
Number of subjects: 66
Study: 12452739

Group type: EXPERIMENTAL
Intervention: Glibenclamide/metformin 2.5/500mg tablets (Glucovance)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glibenclamide 2.5mg with metformin 500mg (Micronase + Glucophage)
Number of subjects: 40
Study: 10086398

Group type: EXPERIMENTAL
Intervention: Full intervention (teacher training, parent education, social competence training)
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Full intervention
Number of subjects: 643

Group type: COMPARATOR
Intervention: Late intervention (grades 5 and 6 only)
Number of subjects: 643
Study: 7555001

Group type: EXPERIMENTAL
Intervention: Quinidine (250 mg) + Diazepam (10 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Quinidine (250 mg) alone
Number of subjects: 8
Study: 2345079

Group type: EXPERIMENTAL
Intervention: Ketanserin (3 to 30 micrograms/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 30
Study: 7437243

Group type: EXPERIMENTAL
Intervention: naproxen sodium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: naproxen sodium (every 6 h)
Number of subjects: 0
Study: 31230925

Group type: EXPERIMENTAL
Intervention: Short-axis approach by two operators
Number of subjects: 100

Group type: COMPARATOR
Intervention: Long-axis approach by two operators
Number of subjects: 100
Study: 30326551

Group type: EXPERIMENTAL
Intervention: Slow Dynamic Stretching (SDS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fast Dynamic Stretching (FDS)
Number of subjects: 18
Study: 28654958

Group type: EXPERIMENTAL
Intervention: FH + WGS group
Number of subjects: 100

Group type: COMPARATOR
Intervention: FH group
Number of subjects: 100
Study: 25362844

Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 89

Group type: COMPARATOR
Intervention: High-dose rate brachytherapy (2×10 Gy) and external beam radiotherapy (25×2 Gy)
Number of subjects: 89
Study: 23040208

Group type: EXPERIMENTAL
Intervention: Oral alendronate 70 mg once weekly
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study: 21555984

Group type: EXPERIMENTAL
Intervention: Thera-Band® Elastic Resistance-Assisted Gait Training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional Occupational Therapy and Conventional Gait Training
Number of subjects: 16
Study: 19300233

Group type: EXPERIMENTAL
Intervention: Interrupted Vicryl sutures
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Continuous polydioxanone suture (PDS)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Continuous Monoplus sutures
Number of subjects: 625
Study: 17761566

Group type: EXPERIMENTAL
Intervention: Microfinance intervention combined with participatory training on HIV, gender norms, domestic violence, and sexuality.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microfinance intervention
Number of subjects: 0
Study: 15561795

Group type: EXPERIMENTAL
Intervention: Computerized protocol
Number of subjects: 484

Group type: COMPARATOR
Intervention: Paper-based protocol
Number of subjects: 484

Group type: COMPARATOR
Intervention: Control group (paper-based)
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Computerized group
Number of subjects: 484

Group type: COMPARATOR
Intervention: First study period (paper-based)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Third study period (paper-based)
Number of subjects: 484
Study: 12150179

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus 19070-2 and Lactobacillus reuteri DSM 12246, 10(10) colony-forming units of each strain twice daily for 5 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus 19070-2 and Lactobacillus reuteri DSM 12246, 10(10) colony-forming units of each strain twice daily for 5 days (early intervention)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (early intervention)
Number of subjects: 30
Study: 9477100

Group type: EXPERIMENTAL
Intervention: Stereotactically guided fine-needle aspiration (SFNA) followed by stereotactically guided core needle biopsy (SCNB)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Stereotactically guided core needle biopsy (SCNB) only
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Ultrasonographically guided fine-needle aspiration (USFNA) followed by ultrasonographically guided core needle biopsy (USCNB)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Ultrasonographically guided core needle biopsy (USCNB) only
Number of subjects: 377
Study: 8682921

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse (Corsodyl)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peroxycarbonate rinse (Kavosan)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peroxyborate rinse (Bocasan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline rinse (negative control)
Number of subjects: 0
Study: 1972847

Group type: EXPERIMENTAL
Intervention: Intradermal injections of PPD (1 in 1000)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intradermal injections of streptokinase/streptodornase (20 mu/5 mu per 0.1 ml)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline control solutions
Number of subjects: 21
Study: 539651

Group type: EXPERIMENTAL
Intervention: Meperidine (Alodan) and promethazine (Phenergan)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Thalamonal
Number of subjects: 96
Study: 29927661

Group type: EXPERIMENTAL
Intervention: Facilitated dissemination approach
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional dissemination approach
Number of subjects: 24

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 24
Study: 28554606

Group type: EXPERIMENTAL
Intervention: CAPI (interviewer-administered comprehensive health and social risk assessments)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: ACASI (self-administered comprehensive health and social risk assessments)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: CAPI
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: ACASI
Number of subjects: 750
Study: 25540305

Group type: EXPERIMENTAL
Intervention: 60 Hz stimulation
Number of subjects: 7

Group type: COMPARATOR
Intervention: 130 Hz stimulation
Number of subjects: 7
Study: 23432801

Group type: EXPERIMENTAL
Intervention: SP monthly and azithromycin (1 g) twice (AZI-SP)
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: SP monthly (monthly SP)
Number of subjects: 1320

Group type: COMPARATOR
Intervention: SP (control)
Number of subjects: 1320
Study: 20796074

Group type: EXPERIMENTAL
Intervention: Thermal stress (GII)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Restricted feeding (GIII)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combined stress (GIV)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (GI)
Number of subjects: 28
Study: 18783417

Group type: EXPERIMENTAL
Intervention: Immediate functional loading with occlusal contact or immediate nonfunctional loading without occlusal contact
Number of subjects: 155

Group type: COMPARATOR
Intervention: One‐stage or two‐stage surgical procedure (control group)
Number of subjects: 155
Study: 16709205

Group type: EXPERIMENTAL
Intervention: Vaginal clindamycin treatment
Number of subjects: 819

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 819
Study: 14998423

Group type: EXPERIMENTAL
Intervention: Tramadol LP 200 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Topalgic 4 x 50mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tramadol LP 200 mg (fasting state)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tramadol LP 200 mg (fed state)
Number of subjects: 30
Study: 10913727

Group type: EXPERIMENTAL
Intervention: carnitine supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo supplementation
Number of subjects: 20
Study: 9368873

Group type: EXPERIMENTAL
Intervention: Prevalence screen detected
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Previously screened
Number of subjects: 250

Group type: COMPARATOR
Intervention: Never screened
Number of subjects: 250
Study: 2062489

Group type: EXPERIMENTAL
Intervention: Argon laser treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (untreated eyes)
Number of subjects: 44
Study: 6849741

Group type: EXPERIMENTAL
Intervention: Indoramin 50 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Indoramin 100 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Indoramin 25 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Indoramin (all doses)
Number of subjects: 5
Study: 30736052

Group type: EXPERIMENTAL
Intervention: Medial-stabilized (MS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Posterior-stabilized (PS)
Number of subjects: 50
Study: 30552587

Group type: EXPERIMENTAL
Intervention: LCPT 0.17 mg/kg/day (n = 37)
Number of subjects: 75

Group type: COMPARATOR
Intervention: PR-Tac 0.20 mg/kg/day (n = 38)
Number of subjects: 75
Study: 28050798

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50,000 IU every 2 weeks for 6 months)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 58
Study: 26941199

Group type: EXPERIMENTAL
Intervention: PICN 260 mg/m2
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: PICN 295 mg/m2
Number of subjects: 180

Group type: COMPARATOR
Intervention: nab-paclitaxel 260 mg/m2
Number of subjects: 180
Study: 25326051

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline serotonin levels
Number of subjects: 0
Study: 22495466

Group type: EXPERIMENTAL
Intervention: Revascularization plus standard medical therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 84
Study: 20028443

Group type: EXPERIMENTAL
Intervention: Non-ablative 1550-nm erbium-doped fractional photothermolysis systems (FPS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ablative 10 600-nm carbon dioxide fractional laser systems (CO(2) FS)
Number of subjects: 8
Study: 18404122

Group type: EXPERIMENTAL
Intervention: omega-6 fatty acids treatment before and after PRK
Number of subjects: 80
Study: 15842976

Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 0
Study: 12432175

Group type: EXPERIMENTAL
Intervention: Fungal carbohydrases (Carbogen) with meal replacement bar (MBR)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (CaCO3) with meal replacement bar (MBR)
Number of subjects: 5
Study: 10500327

Group type: EXPERIMENTAL
Intervention: Waffles containing Enterococcus faecium M-74
Number of subjects: 0
Study: 8942009

Group type: EXPERIMENTAL
Intervention: salmeterol 50 micrograms twice daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: salbutamol and theophylline (control)
Number of subjects: 24
Study: 2025069

Group type: EXPERIMENTAL
Intervention: Primary repair or resection and anastomosis
Number of subjects: 56

Group type: COMPARATOR
Intervention: Diversion (24 colostomy, 3 ileostomy, 1 jejunostomy)
Number of subjects: 56
Study: 906784

Group type: EXPERIMENTAL
Intervention: Gallamine 0.3 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gallamine 0.4 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gallamine 0.5 mg/kg
Number of subjects: 60
Study: 31768936

Group type: EXPERIMENTAL
Intervention: 4-Methylpyrazole (4-MP) administered intravenously alongside APAP.
Number of subjects: 5

Group type: COMPARATOR
Intervention: Acetaminophen (APAP) alone without 4-MP.
Number of subjects: 5
Study: 31738798

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including participatory ergonomics, health promotion activities, and case management for one year.
Number of subjects: 473

Group type: COMPARATOR
Intervention: Usual occupational health care (Control group).
Number of subjects: 473
Study: 27872357

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU) pediatric suspension 7.5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetaminophen (APAP) suspension 10 to 15 mg/kg
Number of subjects: 0
Study: 26124203

Group type: EXPERIMENTAL
Intervention: Siltuximab (11 mg/kg every 3 weeks)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 23271090

Group type: EXPERIMENTAL
Intervention: Helicopter emergency medical systems (HEMS)
Number of subjects: 192422

Group type: COMPARATOR
Intervention: Ground ambulance
Number of subjects: 192422
Study: 21630245

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly
Number of subjects: 566

Group type: COMPARATOR
Intervention: Sulfasalazine titrated to a maximum of 3 gm/day
Number of subjects: 566
Study: 19307812

Group type: EXPERIMENTAL
Intervention: Two-thumb technique (TT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Two-finger technique (TF)
Number of subjects: 64

Group type: COMPARATOR
Intervention: One-hand technique (OH)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Two-hand technique (TH)
Number of subjects: 64
Study: 22294408

Group type: EXPERIMENTAL
Intervention: Delis‐Kaplan Executive Function System (D‐KEFS) Sorting Test
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: WMS‐III Immediate Memory Primary Index (IMI)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: WMS‐III Working Memory Primary Index (WMI)
Number of subjects: 167
Study: 15880316

Group type: EXPERIMENTAL
Intervention: Supportive enteral or parenteral nutrition (1000 kcal/d until patients did not wish to continue)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Supportive enteral or parenteral nutrition
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral nutrition only (control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Parenteral feeding
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Enteral feeding
Number of subjects: 80
Study: 12865481

Group type: COMPARATOR
Intervention: Placebo (P) injections
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Resistance training and placebo (RT+P)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Weekly injections of testosterone (T; 100 mg/week)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Resistance training and testosterone (RT+T)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: All groups (including MA)
Number of subjects: 28
Study: 10215942

Group type: EXPERIMENTAL
Intervention: recombinant FVIII (rFVIII-KOGENATE)
Number of subjects: 58
Study: 7612052

Group type: EXPERIMENTAL
Intervention: Oral racemic propafenone preparation (300 mg)
Number of subjects: 24
Study: 2696433

Group type: EXPERIMENTAL
Intervention: Lactoferrin (L) added to formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron and lactoferrin (LF) added to formula
Number of subjects: 0

Group type: COMPARATOR
Intervention: No added iron and no added lactoferrin (basic)
Number of subjects: 0
Study: 16632

Group type: EXPERIMENTAL
Intervention: Penbutolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 12151246

Group type: EXPERIMENTAL
Intervention: Neural manual therapy technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Indirect manual therapy techniques
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (crossed over to neural manual therapy after 8 weeks)
Number of subjects: 30
Study: 30174418

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) of 1,064 nm, 60 J/cm2, 10 minutes
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) of 785 nm, 8 J/cm2, 8 minutes
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham (HILT placebo)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham (LLLT placebo)
Number of subjects: 68
Study: 27080931

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy (WET)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 126
Study: 24751502

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 μg/kg/min continuous infusion for 24 h)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22810741

Group type: EXPERIMENTAL
Intervention: Thrombolysis with mexidol
Number of subjects: 116

Group type: COMPARATOR
Intervention: Thrombolysis with standard therapy
Number of subjects: 116
Study: 20233178

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (42 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 12
Study: 18384391

Group type: EXPERIMENTAL
Intervention: Local minocycline microspheres
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Local minocycline microspheres (in smokers)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgery alone (in smokers)
Number of subjects: 60
Study: 15607868

Group type: EXPERIMENTAL
Intervention: Pamidronate (90 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 44
Study: 12107600

Group type: EXPERIMENTAL
Intervention: Dofetilide (500 microg twice daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sotalol (160 mg twice daily)
Number of subjects: 12
Study: 10431120

Group type: EXPERIMENTAL
Intervention: PRP-T booster immunization
Number of subjects: 348

Group type: COMPARATOR
Intervention: PRP-D priming
Number of subjects: 348

Group type: COMPARATOR
Intervention: PRP-T priming
Number of subjects: 348

Group type: COMPARATOR
Intervention: No additional PRP-T
Number of subjects: 348
Study: 7599249

Group type: EXPERIMENTAL
Intervention: Geriatric assessment and intervention team (GAIT) services
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual hospital care (Control)
Number of subjects: 108
Study: 2296626

Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 352088

Group type: EXPERIMENTAL
Intervention: 5% guanethidine/1% adrenaline combination
Number of subjects: 63

Group type: COMPARATOR
Intervention: 5% guanethidine alone
Number of subjects: 63

Group type: COMPARATOR
Intervention: 1% adrenaline alone
Number of subjects: 63